Company’s Globally Popular Hemp Cannabidiol (CBD) Oil Brand, [RSHO]™, Now Shipping to all U.S. Territories and Caribbean Island Pharmacy Retail Locations
San Diego, CA – September 23, 2015 – As the U.S. territories and Caribbean Islands wait for medical marijuana to make its debut, Medical Marijuana, Inc. (OTC Pink: MJNA) is proud to immediately offer residents an alternative: Real Scientific Hemp Oil [RSHO]™.
“It is interesting to note that the U.S. territories and Caribbean Islands have recently scheduled medical marijuana within the area as a Schedule 2 substance,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “This means that the local government believes there is some medicinal value in cannabis / marijuana. Nonetheless, we at MJNA are thrilled to have an exclusive agreement that is actively providing non-psychoactive cannabidiol or ‘CBD’ hemp oil products to residents of the U.S. territories and Caribbean Islands.”
Hemp is widely regarded as a “whole food” and “super food.” Medical Marijuana, Inc.’s cannabidiol (CBD) hemp oil is derived from the mature stalk of the hemp plant and is considered a food nutrient delivering the benefits of cannabinoids without the psychotropic/euphoric effects of THC. Hemp oil products from Medical Marijuana, Inc. and its master distributor, HempMeds®, are readily available to ship to all 50 U.S. states, districts and territories plus more than 40 countries around the world.
As part of the agreement, HempMeds has already shipped its first month’s purchase order, and as part of the contract it requires a minimum annual requirement of $1,000,000 USD in sales. The 12-month exclusive distribution agreement for [RSHO]™ includes two annual sales revenue-based exclusivity extension options with one of the largest privately owned pharmaceutical sales and distribution companies in the U.S. territories and Caribbean Islands. This [RSHO]™ authorized distributor holds more than 60 years of proven service to the islands and has effectively opened retail product sales ofcannabidiol (CBD) hemp oil into more than 750 retail pharmacy locations and drugstore chains throughout the Caribbean.
The full scope of the exclusive [RSHO]™ distributor’s sales channel includes: pharmaceutical, consumer goods, health and beauty, general merchandise, grocery, and household goods. The distributor’s vertical market reach is currently to: hospitals, government institutions, community pharmacies, drugstore chains, coop buying food clubs, independent supermarkets, mass merchandise distributors, department stores, drug wholesalers, doctors and U.S. military bases.
With an intense focus on customer satisfaction, the exclusive [RSHO]™ distributor offers advanced technological processes and logistics infrastructure including over 1,200 retails locations we can expand into.
HempMeds has also applied for multiple medical product registrations and we anticipation updating shareholders shortly on that. Though we keep our updates general in nature, we do that to keep the competitive nature. As we continue to solidify markets we will be more transparent regarding those details.
Dr. Titus continues, “It is interesting to note that the RSHO product line has expanded its brand footprint worldwide. We are moving forward extremely well in South America and now with the U.S. territories and Caribbean Islands. MJNA is looking forward to announcing additional international expansion activities in the near future. All of this expansion signifies that consumers are becoming well educated on the benefits of hemp, are looking to add it to their daily diets and, as a result, are ushering its rapid return to the global market place.”
The most widely recognized CBD hemp oil brand in the U.S. and its territories, South America and the Caribbean is Real Scientific
Hemp Oil™. [RSHO]™ product lines offer consumers a wide range of options to include in their daily routines:
[Non-GMO [RSHO]™ contains no pesticides, herbicides or heavy metals. Before becoming a finished product, [RSHO]™ goes through multiple quality tests by the top cannabis industry and food laboratories in the country.
In a video statement from one of the cannabis industry’s top product quality testing authorities, ProVerde Laboratories’ CEO, Dorian A. Des Lauriers, states that his company has tested [RSHO]™ for more than two years. Des Lauriers explains further in the video statement that ProVerde Laboratories is an industry leader in the testing space and is an ISO/IEC 17025:2005 accredited laboratory with one of the broadest scopes of any lab in the industry for both hemp and marijuana testing. ProVerde uses highly sophisticated equipment - the same type of equipment as used by pharmaceutical companies around the world.
For more information on HempMeds and their all-natural hemp oil products, visit: www.hempmeds.com. The Company invites the public to get involved in the conversation of the expanding cannabis industry with HempMeds® through the Company’s social media websites on Facebook and Twitter.
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink: MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
For further information, please contact:
Public Relations contact:
Chief Executive Officer